细胞行业投资

Search documents
开能健康:关于对外投资设立全资子公司的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-09-24 10:13
Core Viewpoint - The company plans to establish a wholly-owned subsidiary in Hainan or Hunan provinces to engage in the cell industry and related mergers and acquisitions, with a registered capital of 100 million RMB [1] Group 1 - The subsidiary will be funded by the company's own capital [1] - The establishment of the subsidiary falls within the general manager's approval authority, thus does not require board approval [1]